Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: Involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Mendivil Perez, Miguel ^a   Jimenez Del Rio, Marlene ^a   Velez Pardo, Carlos ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOELECTRIC POTENTIALS; CELL DEATH; CHEMICAL ACTIVATION; DISEASES; DRUG PRODUCTS; FLAVONOIDS; OXYGEN; PROTEINS;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS-INDUCING FACTORS; C-JUN N-TERMINAL KINASE; GLUCOSE CONCENTRATION; GLUCOSE SENSITIVES; INDUCED APOPTOSIS; SUPEROXIDE RADICAL; TRANSMEMBRANE POTENTIALS;

GLUCOSE;

APOPTOSIS INDUCING FACTOR; CASPASE 3; DJ 1 PROTEIN; GLUCOSE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METFORMIN; PARKIN; PHOSPHATASE AND TENSIN HOMOLOG INDUCED NOVEL KINASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN C JUN; PROTEIN P53; ROTENONE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; HYPERGLYCEMIA; JURKAT CELL LINE; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN EXPRESSION; UPREGULATION; BIOLOGICAL MODEL; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; METABOLISM; NUCLEAR SHAPE; PATHOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; CELL NUCLEUS SHAPE; ENZYME ACTIVATION; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; METFORMIN; MODELS, BIOLOGICAL; ONCOGENE PROTEINS; OXIDATIVE STRESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN KINASES; ROTENONE; SIGNAL TRANSDUCTION; SUPEROXIDES; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84901922609     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/457154     Document Type: Article

References (43)

1. Redaelli A., Laskin B. L., Stephens J. M., Botteman M. F., Pashos C. L., A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). European Journal of Cancer Care 2005 14 1 53 62 2-s2.0-14644438502 10.1111/j.1365-2354.2005.00513.x (Pubitemid 40314386)
2. Lowas S. R., Marks D., Malempati S., Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia. Pediatric Blood and Cancer 2009 52 7 814 818 2-s2.0-67650435068 10.1002/pbc.21980
3. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
4. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., El-Deiry W. S., Golstein P., Green D. R., Hengartner M., Knight R. A., Kumar S., Lipton S. A., Malorni W., Nuñez G., Peter M. E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G., Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death and Differentiation 2009 16 1 3 11 2-s2.0-57649149333 10.1038/cdd.2008.150
5. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nũez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H.-U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G., Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death and Differentiation 2012 19 1 107 120 2-s2.0-84255210700 10.1038/cdd.2011.96
6. Gogvadze V., Targeting mitochondria in fighting cancer. Current Pharmaceutical Design 2011 17 36 4034 4046 2-s2.0-84855231244
7. Chen G., Wang F., Trachootham D., Huang P., Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010 10 6 614 625 2-s2.0-78149360700 10.1016/j.mito.2010.08.001
8. Neuzil J., Dong L. F., Rohlena J., Truksa J., Ralph S. J., Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 2013 13 3 199 208 10.1016/j.mito.2012.07.112
9. Grivennikova V. G., Vinogradov A. D., Partitioning of superoxide and hydrogen peroxide production by mitochondrial respiratory complex I. Biochimica et Biophysica Acta 1827 3 446 454
10. Armstrong J. S., Hornung B., Lecane P., Jones D. P., Knox S. J., Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW. Biochemical and Biophysical Research Communications 2001 289 5 973 978 2-s2.0-0035930930 10.1006/bbrc.2001.6054 (Pubitemid 34076285)
11. Chung W.-G., Miranda C. L., Maier C. S., Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Research 2007 1176 1 133 142 2-s2.0-35148863128 10.1016/j.brainres.2007.07.083 (Pubitemid 47553116)
12. Deng Y.-T., Huang H.-C., Lin J.-K., Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Molecular Carcinogenesis 2010 49 2 141 151 2-s2.0-75849160168 10.1002/mc.20583
13. Tada-Oikawa S., Hiraku Y., Kawanishi M., Kawanishi S., Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. Life Sciences 2003 73 25 3277 3288 2-s2.0-0141996495 10.1016/j.lfs.2003.06.013 (Pubitemid 37237579)
14. Marella M., Byoung B. S., Matsuno-Yagi A., Yagi T., Mechanism of cell death caused by complex I defects in a rat dopaminergic cell line. The Journal of Biological Chemistry 2007 282 33 24146 24156 2-s2.0-34548207775 10.1074/jbc.M701819200 (Pubitemid 47328018)
15. Klintworth H., Newhouse K., Li T., Choi W.-S., Faigle R., Xia Z., Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. Toxicological Sciences 2007 97 1 149 162 2-s2.0-34347259974 10.1093/toxsci/kfm029 (Pubitemid 47072164)
16. Ramachandiran S., Hansen J. M., Jones D. P., Richardson J. R., Miller G. W., Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicological Sciences 2007 95 1 163 171 2-s2.0-33845645902 10.1093/toxsci/kfl125 (Pubitemid 44970055)
17. Hartley A., Stone J. M., Heron C., Cooper J. M., Schapira A. H. V., Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. Journal of Neurochemistry 1994 63 5 1987 1990 2-s2.0-0028127129 (Pubitemid 24326248)
18. Mendivil-Perez M., Jimenez-Del-Rio M., Velez-Pardo C., Glucose starvation induces apoptosis in a model of acute T leukemia dependent on caspase-3 and apoptosis-inducing factor: a therapeutic strategy. Nutrition and Cancer 2013 65 1 99 109 10.1080/01635581.2013.741751
19. Jimenez-Del-Rio M., Velez-Pardo C., The bad, the good, and the ugly about oxidative stress. Oxidative Medicine and Cellular Longevity 2012 2012 13 163913 10.1155/2012/163913
20. Zhang C., Lin M., Wu R., Wang X., Yang B., Levine A. J., Hu W., Feng Z., Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proceedings of the National Academy of Sciences of the United States of America 2011 108 39 16259 16264 2-s2.0-80053635472 10.1073/pnas.1113884108
21. Henn I. H., Bouman L., Schlehe J. S., Schlierf A., Schramm J. E., Wegener E., Nakaso K., Culmsee C., Berninger B., Krappmann D., Tatzelt J., Winklhofer K. F., Parkin mediates neuroprotection through activation of I B kinase/nuclear factor- B signaling. Journal of Neuroscience 2007 27 8 1868 1878 2-s2.0-33847191686 10.1523/JNEUROSCI.5537-06.2007
22. Sha D., Chin L.-S., Li L., Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF- B signaling. Human Molecular Genetics 2010 19 2 352 363 2-s2.0-77949478474 10.1093/hmg/ddp501
23. Liu H., Wang M., Li M., Expression and role of DJ-1 in leukemia. Biochemical and Biophysical Research Communications 2008 375 3 477 483 10.1016/j.bbrc.2008.08.046
24. Agirre X., Román-Gómez J., Vázquez I., Jiménez-Velasco A., Garate L., Montiel-Duarte C., Artieda P., Cordeu L., Lahortiga I., Calasanz M. J., Heiniger A., Torres A., Minna J. D., Prósper F., Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer 2006 118 8 1945 1953 2-s2.0-33645215136 10.1002/ijc.21584
25. Rosilio C., Lounnas N., Nebout M., The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells. Cancer Letters 2013 336 1 114 126 10.1016/j.canlet.2013.04.015
26. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J. A., Robinson J. P., Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. The Journal of Biological Chemistry 2003 278 10 8516 8525 2-s2.0-0037424245 10.1074/jbc.M210432200 (Pubitemid 36800604)
27. Takada Y., Mukhopadhyay A., Kundu G. C., Mahabeleshwar G. H., Singh S., Aggarwal B. B., Hydrogen peroxide activates NF- B through tyrosine phosphorylation of I B α and serine phosphorylation of p65: evidence for the involvement of I B α kinase and Syk protein-tyrosine kinase. The Journal of Biological Chemistry 2003 278 26 24233 24241 2-s2.0-0037591401 10.1074/jbc.M212389200 (Pubitemid 36830260)
28. Kamata H., Manabe T., Oka S.-I., Kamata K., Hirata H., Hydrogen peroxide activates I B kinases through phosphorylation of serine residues in the activation loops. The FEBS Letters 2002 519 1-3 231 237 2-s2.0-0037157177 10.1016/S0014-5793(02)02712-6 (Pubitemid 34522025)
29. Radhakrishnan S. K., Kamalakaran S., Pro-apoptotic role of NF- B: implications for cancer therapy. Biochimica et Biophysica Acta-Reviews on Cancer 2006 1766 1 53 62 2-s2.0-33746829168 10.1016/j.bbcan.2006.02.001 (Pubitemid 44175630)
30. McNeill-Blue C., Wetmore B. A., Sanchez J. F., Freed W. J., Alex Merrick B., Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine. Brain Research 2006 1112 1 1 15 2-s2.0-33748536416 10.1016/j.brainres.2006.07.024 (Pubitemid 44363064)
31. Son Y.-O., Jang Y.-S., Shi X., Lee J.-C., Activation of JNK and c-Jun is involved in glucose oxidase-mediated cell death of human lymphoma cells. Molecules and Cells 2009 28 6 545 551 2-s2.0-76649091572 10.1007/s10059-009- 0149-1
32. Mattes M. J., Apoptosis assays with lymphoma cell lines: problems and pitfalls. British Journal of Cancer 2007 96 6 928 936 2-s2.0-33947418083 10.1038/sj.bjc.6603663 (Pubitemid 46452293)
33. Sevrioukova I. F., Apoptosis-inducing factor: structure, function, and redox regulation. Antioxidants and Redox Signaling 2011 14 12 2545 2579 2-s2.0-79957459076 10.1089/ars.2010.3445
34. Wilson M. A., The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxidants and Redox Signaling 2011 15 1 111 122 2-s2.0-79958199102 10.1089/ars.2010.3481
35. Taira T., Saito Y., Niki T., Iguchi-Ariga S. M. M., Takahashi K., Ariga H., DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Reports 2004 5 2 213 218 2-s2.0-1642527499 10.1038/sj.embor.7400074 (Pubitemid 38401204)
36. Blackinton J., Lakshminarasimhan M., Thomas K. J., Ahmad R., Greggio E., Raza A. S., Cookson M. R., Wilson M. A., Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. The Journal of Biological Chemistry 2009 284 10 6476 6485 2-s2.0-65249159732 10.1074/jbc.M806599200
37. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T. M., Thomas B., Han S. K., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T. M., Dawson V. L., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14807 14812 2-s2.0-35548972027 10.1073/pnas.0703219104 (Pubitemid 350003224)
38. Cookson M. R., Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harbor Perspectives in Medicine 2012 2 9 a009415
39. Yang Y. X., Muqit M. M. K., Latchman D. S., Induction of parkin expression in the presence of oxidative stress. European Journal of Neuroscience 2006 24 5 1366 1372 2-s2.0-33748753935 10.1111/j.1460-9568.2006.04998.x (Pubitemid 44401659)
40. Riganti C., Gazzano E., Polimeni M., Aldieri E., Ghigo D., The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radical Biology and Medicine 2012 53 3 421 436 10.1016/j.freeradbiomed. 2012.05.006
41. Grimaldi C., Chiarini F., Tabellini G., Ricci F., Tazzari P. L., Battistelli M., Falcieri E., Bortul R., Melchionda F., Iacobucci I., Pagliaro P., Martinelli G., Pession A., Barata J. T., McCubrey J. A., Martelli A. M., AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia 2012 26 1 91 100 2-s2.0-84856757946 10.1038/leu.2011.269
42. Owen M. R., Doran E., Halestrap A. P., Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 2000 348 part 3 607 614 2-s2.0-0034659785 10.1042/0264-6021:3480607 (Pubitemid 30410251)
43. Rosilio C., Ben-Sahra I., Bost F., Peyron J.-F., Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia. Cancer Letters 2014 346 2 188 196 10.1016/j.canlet.2014.01.006